Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells

BioResearch Open Access

Volumn 1, Issue 5, 2012, Pages 205-214

  Li, Yan ^a   Ma, Teng ^a  

^a FAMU FSU COLLEGE OF ENGINEERING   (United States)

Author keywords

Cell banking; Cryopreservation; Human pluripotent stem cell

Indexed keywords

CRYOPROTECTIVE AGENT; CYCLIC GMP; DIMETHYL SULFOXIDE; ETHYLENE GLYCOL; GLYCEROL; HETASTARCH; POVIDONE; PROPYLENE GLYCOL; REACTIVE OXYGEN METABOLITE;

ANOIKIS; APOPTOSIS; BIOPROCESS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; COOLING; CRYOPRESERVATION; EXTRACELLULAR MATRIX; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; VITRIFICATION; WARMING;

EID: 85042657366     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0224     Document Type: Review

References (102)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
2. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.
3. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
4. Bretzner F, Gilbert F, Baylis F, et al. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell. 2011;8:468-475.
5. Wirth E, 3rd, Lebkowski JS, Lebacqz K. Response to Frederic Bretzner et al. "Target populations for first-in-human embryonic stem cell research in spinal cord injury". Cell Stem Cell. 2011;8:476-478.
6. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713-720.
7. Serra M, Brito C, Correia C, et al. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 2012;30:350-359.
8. Berz D, McCormack EM, Winer ES, et al. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007;82:463-472.
9. Thirumala S, Goebel WS, Woods EJ. Clinical grade adult stem cell banking. Organogenesis. 2009;5:143-154.
10. Coopman K. Large-scale compatible methods for the preservation of human embryonic stem cells: current perspectives. Biotechnol Prog. 2011;27:1511-1521.
11. Katkov, II, Kim MS, Bajpai R, et al. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology. 2006;53:194-205.
12. Hunt CJ. Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother. 2011;38: 107-123.
13. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247:C125-C142.
14. Mazur P. Stopping biological time. The freezing of living cells. Ann NY Acad Sci. 1988;541:514-531.
15. Fuller BJ. Cryoprotectants: the essential antifreezes to protect life in the frozen state. Cryo Lett. 2004;25:375-388.
16. Meryman HT. Cryopreservation of living cells: principles and practice. Transfusion. 2007;47:935-945.
17. Kashuba Benson CM, Benson JD, Critser JK. An improved cryopreservation method for a mouse embryonic stem cell line. Cryobiology. 2008;56:120-130.
18. Hunt CJ, Armitage SE, Pegg DE. Cryopreservation of umbilical cord blood: 1. Osmotically inactive volume, hydraulic conductivity and permeability of CD34(+) cells to dimethyl sulphoxide. Cryobiology. 2003;46:61-75.
19. Gao DY, Chang Q, Liu C, et al. Fundamental cryobiology of human hematopoietic progenitor cells. I: osmotic characteristics and volume distribution. Cryobiology. 1998;36:40-48.
20. Katkov II. A two-parameter model of cell membrane permeability for multisolute systems. Cryobiology. 2000;40:64-83.
21. Solves P, Mirabet V, Perales A, et al. Banking strategies for improving the hematopoietic stem cell content of umbilical cord blood units for transplantation. Curr Stem Cell Res Ther. 2008;3:79-84.
22. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010;28:585-596.
23. Liu Y, Xu X, Ma X, et al. Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol Prog. 2010;26:1635-1643.
24. Ginis I, Grinblat B, Shirvan MH. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods. 2012;18:453-463.
25. Nicoud IB, Clarke DM, Taber G, et al. Cryopreservation of umbilical cord blood with a novel freezing solution that mimics intracellular ionic composition. Transfusion. 2012.
26. Luo K, Wu G, Wang Q, et al. Effect of dimethylsulfoxide and hydroxyethyl starch in the preservation of fractionated human marrow cells. Cryobiology. 1994;31:349-354.
27. Thirumala S, Wu X, Gimble JM, et al. Evaluation of polyvinylpyrrolidone as a cryoprotectant for adipose tissuederived adult stem cells. Tissue Eng Part C Methods. 2010; 16:783-792.
28. Grein TA, Freimark D, Weber C, et al. Alternatives to dimethylsulfoxide for serum-free cryopreservation of humanmesenchymal stem cells. Int J Artif Organs. 2010;33:370-380.
29. Kirouac DC, Zandstra PW. The systematic production of cells for cell therapies. Cell Stem Cell. 2008;3:369-381.
30. Heidemann R, Lunse S, Tran D, et al. Characterization of cellbanking parameters for the cryopreservation of mammalian cell lines in 100-mL cryobags. Biotechnol Prog. 2010;26: 1154-1163.
31. Fleming KK, Hubel A. Cryopreservation of hematopoietic and non-hematopoietic stem cells. Transfus Apher Sci. 2006;34:309-315.
32. Heng BC, Ye CP, Liu H, et al. Loss of viability during freezethaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci. 2006;13:433-445.
33. Ichikawa H, Nakata N, Abo Y, et al. Gene pathway analysis of the mechanism by which the Rho-associated kinase inhibitor Y-27632 inhibits apoptosis in isolated thawed human embryonic stem cells. Cryobiology. 2012;64:12-22.
34. Fortunato SJ, Menon R. IL-1 beta is a better inducer of apoptosis in human fetal membranes than IL-6. Placenta. 2003;24:922-928.
35. Kim SG, Jong HS, Kim TY, et al. Transforming growth factorbeta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol Biol Cell. 2004;15:420-434.
36. Park SY, Kim EY, Cui XS, et al. Increase in DNA fragmentation and apoptosis-related gene expression in frozenthawed bovine blastocysts. Zygote. 2006;14:125-131.
37. Heng BC, Clement MV, Cao T. Caspase inhibitor Z-VADFMK enhances the freeze-thaw survival rate of human embryonic stem cells. Biosci Rep. 2007;27:257-264.
38. Xu X, Cowley S, Flaim CJ, et al. Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation. Biotechnol Prog. 2010;26:781-788.
39. Taddei ML, Giannoni E, Fiaschi T, et al. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226: 380-393.
40. Grossmann J. Molecular mechanisms of "detachmentinduced apoptosis-anoikis". Apoptosis. 2002;7:247-260.
41. Wang X, Lin G, Martins-Taylor K, et al. Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells. J Biol Chem. 2009;284:34054-34064.
42. Krawetz RJ, Li X, Rancourt DE. Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays. 2009;31:336-343.
43. Wong RC, Dottori M, Koh KL, et al. Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. Biochem Biophys Res Commun. 2006;344:181-188.
44. Wong RC, Pebay A, Nguyen LT, et al. Presence of functional gap junctions in human embryonic stem cells. Stem Cells. 2004;22:883-889.
45. Ichikawa H, Yoshie S, Shirasawa S, et al. Freeze-thawing single human embryonic stem cells induce e-cadherin and actin filament network disruption via g13 signaling. Cryo Lett. 2011;32:516-524.
46. Xu Y, Zhu X, Hahm HS, et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci USA. 2010;107:8129-8134.
47. Ji L, de Pablo JJ, Palecek SP. Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng. 2004;88: 299-312.
48. Mittler R. Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci. 2002;7:405-410.
49. Xu X, Cowley S, Flaim CJ, et al. The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells. Biotechnol Prog. 2010;26:827-837.
50. Rauen U, de Groot H. Cold-induced release of reactive oxygen species as a decisive mediator of hypothermia injury to cultured liver cells. Free Radic Biol Med. 1998;24:1316-1323.
51. Rauen U, de Groot H. Mammalian cell injury induced by hypothermia-the emerging role for reactive oxygen species. Biol Chem. 2002;383:477-488.
52. Mathew AJ, Hollister WR, Addona T, et al. Vitamin E and EDTA improve the efficacy of hypothermosol-implication of apoptosis. In Vitro Mol Toxicol. 1999;12:163-172.
53. Ostrowska A, Gu K, Bode DC, et al. Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform. Arch Toxicol. 2009;83:493-502.
54. Lakey JR, Rajotte RV, Fedorow CA, et al. Islet cryopreservation using intracellular preservation solutions. Cell Transplant. 2001;10:583-589.
55. Baust JM, Vogel MJ, Van Buskirk R, et al. A molecular basis of cryopreservation failure and its modulation to improve cell survival. Cell Transplant. 2001;10:561-571.
56. Kim GA, Lee ST, Ahn JY, et al. Improved viability of freezethawed embryonic stem cells after exposure to glutathione. Fertil Steril. 2010;94:2409-2412.
57. Carpenter MK, Frey-Vasconcells J, Rao MS. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol. 2009;27:606-613.
58. Heng BC, Kuleshova LL, Bested SM, et al. The cryopreservation of human embryonic stem cells. Biotechnol Appl Biochem. 2005;41:97-104.
59. Ali J, Shelton JN. Successful vitrification of day-6 sheep embryos. J Reprod Fertil. 1993;99:65-70.
60. Ali J, Shelton JN. Vitrification of preimplantation stages of mouse embryos. J Reprod Fertil. 1993;98:459-465.
61. Vajta G, Holm P, Kuwayama M, et al. Open pulled straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev. 1998;51:53-58.
62. Yokota Y, Sato S, Yokota M, et al. Successful pregnancy following blastocyst vitrification: case report. Hum Reprod. 2000;15:1802-1803.
63. Reubinoff BE, Pera MF, Vajta G, et al. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod. 2001;16:2187-2194.
64. Li Y, Tan JC, Li LS. Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril. 2010;93:999-1005.
65. Richards M, Fong CY, Tan S, et al. An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells. Stem Cells. 2004;22:779-789.
66. Nishigaki T, Teramura Y, Nasu A, et al. Highly efficient cryopreservation of human induced pluripotent stem cells using a dimethyl sulfoxide-free solution. Int J Dev Biol. 2011;55:305-311.
67. Li T, Zhou C, Liu C, et al. Bulk vitrification of human embryonic stem cells. Hum Reprod. 2008;23:358-364.
68. Li T, Mai Q, Gao J, et al. Cryopreservation of human embryonic stem cells with a new bulk vitrification method. Biol Reprod. 2010;82:848-853.
69. Heng BC, Bested SM, Chan SH, et al. A proposed design for the cryopreservationof intact andadherenthumanembryonic stem cell colonies. In Vitro Cell Dev BiolAnim. 2005;41:77-79.
70. Beier AF, Schulz JC, Dorr D, et al. Effective surface-based cryopreservation of human embryonic stem cells by vitrification. Cryobiology. 2011;63:175-185.
71. Ware CB, Nelson AM, Blau CA. Controlled-rate freezing of human ES cells. Biotechniques. 2005;38:879-880, 882-873.
72. Yang PF, Hua TC, Wu J, et al. Cryopreservation of human embryonic stem cells: a protocol by programmed cooling. Cryo Lett. 2006;27:361-368.
73. Lee JY, Lee JE, Kim DK, et al. High concentration of synthetic serum, stepwise equilibration and slow cooling as an efficient technique for large-scale cryopreservation of human embryonic stem cells. Fertil Steril. 2010;93:976-985.
74. Valbuena D, Sanchez-Luengo S, Galan A, et al. Efficient method for slow cryopreservation of human embryonic stem cells in xeno-free conditions. Reprod Biomed Online. 2008;17:127-135.
75. Ha SY, Jee BC, Suh CS, et al. Cryopreservation of human embryonic stem cells without the use of a programmable freezer. Hum Reprod. 2005;20:1779-1785.
76. Wu CF, Tsung HC, Zhang WJ, et al. Improved cryopreservation of human embryonic stem cells with trehalose. Reprod Biomed Online. 2005;11:733-739.
77. T'Joen V, De Grande L, Declercq H, et al. An efficient, economical slow-freezing method for large-scale human embryonic stem cell banking. Stem Cells Dev. 2012;21:721-728.
78. Holm F, Strom S, Inzunza J, et al. An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells. Hum Reprod. 2010;25:1271-1279.
79. Amps KJ, Jones M, Baker D, et al. In situ cryopreservation of human embryonic stem cells in gas-permeable membrane culture cassettes for high post-thaw yield and good manufacturing practice. Cryobiology. 2010;60:344-350.
80. Nie Y, Bergendahl V, Hei DJ, et al. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog. 2009;25:20-31.
81. Lippens E, Cornelissen M. Slow cooling cryopreservation of cell-microcarrier constructs. Cells Tissues Organs. 2010;192: 177-186.
82. Serra M, Correia C, Malpique R, et al. Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One. 2011;6:e23212.
83. Li X, Meng G, Krawetz R, et al. The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells Dev. 2008;17:1079-1085.
84. Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25:681-686.
85. Martin-Ibanez R, Unger C, Stromberg A, et al. Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod. 2008;23:2744-2754.
86. Baharvand H, Salekdeh GH, Taei A, et al. An efficient and easy-to-use cryopreservation protocol for human ES and iPS cells. Nat Protoc. 2010;5:588-594.
87. Li X, Krawetz R, Liu S, et al. ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum Reprod. 2009;24:580-589.
88. Mollamohammadi S, Taei A, Pakzad M, et al. A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum Reprod. 2009;24:2468-2476.
89. Claassen DA, Desler MM, Rizzino A. ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol Reprod Dev. 2009;76:722-732.
90. Barbaric I, Jones M, Buchner K, et al. Pinacidil enhances survival of cryopreserved human embryonic stem cells. Cryobiology. 2011;63:298-305.
91. Katkov II, Kan NG, Cimadamore F, et al. DMSO-free programmed cryopreservation of fully dissociated and adherent human induced pluripotent stem cells. Stem Cells Int. 2011;2011:981606.
92. Zweigerdt R, Olmer R, Singh H, et al. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc. 2011;6:689-700.
93. Oh SK, Chen AK, Mok Y, et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009;2:219-230.
94. Sensebe L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther. 2011;22:19-26.
95. Brunette E, Li Y, Yeganeh E, et al. Production of human embryonic stem cell master cell bank for therapeutic use using serum-free non-conditioned medium. 3rd Annual Meeting of ISSCR 2005; June 23-25, San Francisco, CA: Poster Number 641.
96. Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011;8:424-429.
97. Li Y, Powell S, Brunette E, et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng. 2005;91: 688-698.
98. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19:971-974.
99. Melkoumian Z, Weber JL, Weber DM, et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol. 2010;28:606-610.
100. Ausubel LJ, Lopez PM, Couture LA. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol Biol. 2011;767:147-159.
101. Chen VC, Couture SM, Ye J, et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 2012;8:388-402.
102. Xu C, Police S, Hassanipour M, et al. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med. 2011;6:53-66